Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bogni

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Tumori|March 1, 1997
The contribution of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) in the preoperative detection of axillary metastases of breast cancer: the experience of the National Cancer Institute of MilanF Crippa, R Agresti, V D Donne, et al.
International Journal of Oncology|May 6, 2011
Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancerE Bombardieri, F Crippa, L Maffioli, et al.
European Journal of Nuclear Medicine|November 18, 1998
Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observationF Crippa, E Seregni, R Agresti, et al.
Leukemia|December 13, 2005
Genome-wide approach to identify risk factors for therapy-related myeloid leukemiaA Bogni, C Cheng, W Liu, et al.
Tumori|July 1, 1997
The influence of blood glucose levels on [18F]fluorodeoxyglucose (FDG) uptake in cancer: a PET study in liver metastases from colorectal carcinomasF Crippa, C Gavazzi, F Bozzetti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 1998
Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancerF Crippa, R Agresti, E Seregni, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 25, 2019
Anti-PSMA <sup>124</sup>I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principleB Frigerio, S Morlino, E Luison, et al.
International Journal of Pharmaceutics|August 8, 2016
Niosomal approach to brain delivery: Development, characterization and in vitro toxicological studiesC Ingallina, F Rinaldi, A Bogni, et al.
Leukemia|August 4, 2007
Genome scan implicates adhesion biological pathways in secondary leukemiaC Hartford, W Yang, C Cheng, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2013
Treatment with tandem [90Y]DOTA-TATE and [177Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapyE Seregni, M Maccauro, C Chiesa, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Tumori|March 1, 1997
The contribution of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) in the preoperative detection of axillary metastases of breast cancer: the experience of the National Cancer Institute of MilanF Crippa, R Agresti, V D Donne, et al.
International Journal of Oncology|May 6, 2011
Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancerE Bombardieri, F Crippa, L Maffioli, et al.
European Journal of Nuclear Medicine|November 18, 1998
Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observationF Crippa, E Seregni, R Agresti, et al.
Leukemia|December 13, 2005
Genome-wide approach to identify risk factors for therapy-related myeloid leukemiaA Bogni, C Cheng, W Liu, et al.
Tumori|July 1, 1997
The influence of blood glucose levels on [18F]fluorodeoxyglucose (FDG) uptake in cancer: a PET study in liver metastases from colorectal carcinomasF Crippa, C Gavazzi, F Bozzetti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 1998
Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancerF Crippa, R Agresti, E Seregni, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 25, 2019
Anti-PSMA <sup>124</sup>I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principleB Frigerio, S Morlino, E Luison, et al.
International Journal of Pharmaceutics|August 8, 2016
Niosomal approach to brain delivery: Development, characterization and in vitro toxicological studiesC Ingallina, F Rinaldi, A Bogni, et al.
Leukemia|August 4, 2007
Genome scan implicates adhesion biological pathways in secondary leukemiaC Hartford, W Yang, C Cheng, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2013
Treatment with tandem [90Y]DOTA-TATE and [177Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapyE Seregni, M Maccauro, C Chiesa, et al.
Pageof 5